ES-481 for Uncontrolled Glioma-Associated Epilepsy and Assessment for Potential Anti-Tumorigenic Effect in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant Tumors

NCT04737174 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Lack of identifiable patients

Conditions

Epilepsy; Seizure

Interventions

DRUG: ES-481

Sponsor

ES Therapeutics Australia Pty Ltd